Physician profile
Daniel Jones
NPI 1538169883
$811.25
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2021: $33.74 · 2022: $78.22 · 2023: $296 · 2024: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $219.65 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $149.84 | 2023 | Gps III Platelet Concentration System |
| Abiomed | $138.95 | 2024 | Impella |
| Stryker Corporation | $93.09 | 2023-2024 | Mistral-Air, Inspace |
| Depuy Synthes Sales INC. | $69.02 | 2019-2022 | |
| Ermi LLC | $25.25 | 2023 | |
| Ferring Pharmaceuticals INC. | $23.20 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $20.15 | 2023 | Rexulti |
| Lundbeck LLC | $19.97 | 2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $17.66 | 2023 | Spravato |
| Lilly USA, LLC | $17.27 | 2023 | Jardiance |
| Novo Nordisk INC | $17.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.